PUBLISHER: The Business Research Company | PRODUCT CODE: 1948368
PUBLISHER: The Business Research Company | PRODUCT CODE: 1948368
A tubeless insulin pump is a wearable medical device designed for people with diabetes to provide continuous insulin delivery without the use of external tubing. It adheres directly to the skin and communicates wirelessly with a handheld controller, offering a more convenient and discreet method of insulin administration.
The primary types of tubeless insulin pumps include wearable and implantable insulin pumps. Wearable pumps are compact devices worn on the body that administer continuous doses of short-acting insulin subcutaneously, minimizing the need for multiple daily injections. These pumps utilize technologies such as continuous glucose monitoring (CGM), integrated pump systems, and standard tubeless pumps, and are utilized by end users including hospitals, pharmacies, e-commerce platforms, and others.
Tariffs are impacting the tubeless insulin pump market by increasing the cost of imported components such as bluetooth modules, cgm sensors, and medical-grade polymers. Segments like wearable and bluetooth-enabled pumps are particularly impacted, with regions including North America and Asia-Pacific facing higher import duties. This has led to elevated production costs and potential price increases for end users. On the positive side, tariffs have encouraged domestic manufacturing, stimulated innovation in pump technology, and supported local supply chain development.
The tubeless insulin pump market research report is one of a series of new reports from The Business Research Company that provides tubeless insulin pump market statistics, including tubeless insulin pump industry global market size, regional shares, competitors with a tubeless insulin pump market share, detailed tubeless insulin pump market segments, market trends and opportunities, and any further data you may need to thrive in the tubeless insulin pump industry. This tubeless insulin pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tubeless insulin pump market size has grown rapidly in recent years. It will grow from $2.2 billion in 2025 to $2.63 billion in 2026 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to limited availability of tubeless insulin pumps, reliance on conventional insulin delivery methods, increasing prevalence of diabetes, growing hospital adoption of insulin pumps, early integration of basic cgm systems.
The tubeless insulin pump market size is expected to see rapid growth in the next few years. It will grow to $5.28 billion in 2030 at a compound annual growth rate (CAGR) of 19.0%. The growth in the forecast period can be attributed to development of advanced wearable and implantable insulin pumps, rising integration of ai and smart monitoring systems, expansion of remote patient monitoring, increasing patient awareness and adoption, growth in e-commerce and telemedicine channels. Major trends in the forecast period include growing adoption of wearable insulin pumps among diabetic patients, integration of continuous glucose monitoring (cgm) with tubeless pumps, demand for bluetooth-enabled and remote-controlled pumps, increasing preference for disposable and reusable patch pumps, expansion of e-commerce channels for insulin pump distribution.
The rising prevalence of diabetes is expected to drive the growth of the tubeless insulin pump market in the coming years. Diabetes is a chronic condition characterized by high blood sugar due to the body's inability to produce or effectively use insulin. The increase in diabetes cases is largely linked to rising obesity rates, which are strongly associated with poor diet and physical inactivity. Tubeless insulin pumps help manage diabetes by delivering continuous, controlled doses of insulin without the need for multiple daily injections, effectively regulating blood sugar levels. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people worldwide were living with diabetes. This number is projected to more than double, reaching 1.3 billion by 2050. Consequently, the growing prevalence of diabetes is fueling demand for tubeless insulin pumps.
Key players in the tubeless insulin pump market are focusing on developing advanced solutions, such as basal-only insulin pods, to provide simplified and cost-effective insulin delivery for individuals with type 2 diabetes who require only background insulin support. A basal-only insulin pod is a wearable pump that delivers a continuous background dose of insulin to help control blood sugar levels, primarily for those with type 2 diabetes. In April 2023, Insulet Corporation, a US-based medical device company, launched Omnipod GO, an insulin delivery device approved for use in adults with type 2 diabetes who would normally receive daily long-acting insulin injections. Omnipod GO is a wearable, independent device that delivers a constant rate of rapid-acting insulin for 72 hours. The tubeless and waterproof pod comes in seven pre-programmed daily rates ranging from 10 to 40 units and operates without the need for a mobile device.
In January 2023, Tandem Diabetes Care, a US-based insulin delivery and diabetes technology company, acquired AMF Medical SA for an undisclosed amount. This acquisition supports Tandem's sustainability initiatives by reducing battery waste through the Sigi pump's rechargeable design while expanding its portfolio of advanced insulin delivery solutions. AMF Medical SA, based in Switzerland, specializes in the manufacture of reusable patch (tubeless) insulin pumps.
Major companies operating in the tubeless insulin pump market are F. Hoffmann-La Roche AG, Sanofi SA, Abbott Laboratories, Medtronic plc, Eli Lilly and Company, Becton Dickinson & Company, Fresenius Kabi AG, Terumo Corporation, Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Ascensia Diabetes Care, MicroTech Medical, Menarini Diagnostics, Bigfoot Biomedical, Debiotech SA, Medtrum Technologies Inc., Diabeloop, SOOIL Development, Beta Bionics.
North America was the largest region in the tubeless insulin pump market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tubeless insulin pump market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the tubeless insulin pump market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The tubeless insulin pump market consists of sales of infusion sets, insertion tools, adhesives pods, and handheld or smartphone-based controllers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tubeless Insulin Pump Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses tubeless insulin pump market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for tubeless insulin pump ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tubeless insulin pump market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.